What Schroders' second LTAF round actually bought

The investments, announced on 29 April 2026, were made through the UK Innovation Long-term Asset Fund (LTAF), according to Schroders Capital. The second funding round drew primarily on capital held by local government pension schemes, following a £500m first close in 2024 backed by Standard Life (then Phoenix) and the British Business Bank.

Four portfolio companies were named. Wayve, the autonomous vehicle developer, was valued at more than $4.5bn after a SoftBank-led round, as reported by multiple outlets at the time. Elevenlabs, the AI voice synthesis company, has seen rapid revenue growth and reached a multi-billion-dollar valuation in recent funding rounds. Luminance, a Cambridge spinout applying AI to legal document review, and Aavantgarde Bio, a gene therapy venture, round out the disclosed names.

In the LTAF's first round, Schroders backed AI video platform Synthesia and drug development scale-up Draig Therapeutics, according to the firm's own disclosures.

"These companies are at the forefront of high-impact, world-class innovation, tackling enduring social need, from critical research into medical therapies, to powering the future of our essential industries," said Harry Raikes, head of UK venture investments at Schroders Capital.

The headline figure, however, deserves scrutiny. Spread across multiple companies at late-stage valuations, £100m buys relatively modest stakes. A single cheque into a company valued north of $4.5bn might amount to a low single-digit percentage holding. For context, the SoftBank-led round in Wayve alone reportedly exceeded $1bn. Whether pension-sourced capital at this scale shifts the dial for the UK venture ecosystem, or simply provides co-investment alongside existing institutional investors, is an open question.

How the LTAF wrapper opens venture to pension capital

The LTAF is a regulatory structure introduced by the Financial Conduct Authority specifically to allow defined-contribution and other pension schemes to invest in illiquid asset classes, including venture capital, infrastructure, and private equity.

Traditional VC fund structures, typically organised as limited partnerships with 10-year lock-ups and capital calls, sit uncomfortably alongside pension fund requirements for daily or periodic dealing, transparent pricing, and robust governance reporting. The LTAF addresses this by imposing a regulated, open-ended fund framework with longer redemption notice periods, typically between 90 and 180 days, while still permitting investment in illiquid assets.

The structure also carries FCA-mandated requirements around valuation frequency, depositary oversight, and investor disclosure that go beyond what a standard venture limited partnership would offer. For pension trustees accustomed to listed equity and bond mandates, these safeguards are a prerequisite.

The British Business Bank's involvement in the UK Innovation LTAF's first close introduced a layer of public co-investment. While the precise terms of any first-loss or risk-sharing arrangement have not been fully disclosed, the Bank's participation was designed to de-risk early allocations and encourage pension schemes to commit capital they might otherwise withhold. This model echoes approaches used in other jurisdictions where public balance sheets have been deployed to catalyse private pension investment into venture.

For UK scale-ups, the practical implication is a new class of investor with different expectations. Pension fund limited partners will likely demand more structured reporting, clearer governance frameworks, and greater visibility on exit timelines than a typical VC fund-of-funds or family office.

The Mansion House Accord: progress so far

The backdrop to Schroders' deployment is the Mansion House Accord, signed in 2025 by 17 of Britain's largest pension providers. Signatories committed to allocating at least five per cent of their default workplace pension portfolios to private markets and UK infrastructure by 2030.

The gap the Accord seeks to close is substantial. UK defined-contribution pension schemes have historically allocated less than two per cent of assets to unlisted investments, according to industry estimates. By contrast, Canada's major pension plans, including the Canada Pension Plan Investment Board (CPPIB) and the Ontario Teachers' Pension Plan (OTPP), routinely allocate between 15 and 30 per cent of total assets to private equity, venture capital, and infrastructure. Australia's superannuation funds, such as AustralianSuper and UniSuper, similarly allocate in the range of 10 to 20 per cent to unlisted assets, according to their published portfolio disclosures.

The structural reasons for the UK's conservatism are well documented. Decades of regulatory pressure following pension fund failures, the shift from defined-benefit to defined-contribution schemes, and a culture of liability-driven investment have pushed UK pension capital overwhelmingly into gilts, investment-grade credit, and listed equities.

Publicly reported progress against the Accord's five per cent target has been limited. Several signatories have announced intentions to increase private market allocations, but concrete deployment figures remain scarce. Chancellor Rachel Reeves said the UK Innovation LTAF's latest round would help "bridge the gap between the UK's investment pools and the high-potential firms that will help drive the next phase of growth across the UK," as reported by City AM.

Whether the Accord's voluntary commitments translate into sustained capital flows, or remain largely aspirational, will depend on whether vehicles like the LTAF can demonstrate returns competitive with listed market alternatives over a full cycle.

What this means for UK scale-ups raising growth rounds

For founders and boards at UK scale-ups approaching Series B and beyond, the emergence of pension-backed venture capital introduces both opportunity and complexity.

The opportunity is straightforward: a potentially large new pool of patient, long-term capital. UK pension assets under management exceed £2 trillion across defined-benefit and defined-contribution schemes. Even a modest shift in allocation towards venture, if the Mansion House Accord's five per cent target were met across the industry, could unlock tens of billions of pounds for private markets, though only a fraction would flow to early-stage and growth-stage ventures.

The complexity lies in what pension fund capital demands. Unlike traditional VC funds, which operate with high tolerance for binary outcomes and long periods of illiquidity, pension schemes are answerable to millions of individual savers and overseen by trustees with fiduciary duties shaped by decades of regulatory expectation. Governance standards, ESG reporting, and transparency on fees and valuations will be non-negotiable.

Liquidity terms also matter. The LTAF's redemption windows, while longer than daily-dealt funds, are still shorter than a standard VC fund's lock-up. Fund managers must therefore construct portfolios that balance illiquid venture positions with sufficient liquidity buffers, potentially constraining the proportion of capital that reaches the earliest-stage companies.

There is also the question of scale. The UK Innovation LTAF's £500m first close and subsequent £100m deployment are meaningful as proof of concept but modest relative to the venture funding gap. The British Business Bank's own analysis has identified a persistent shortfall in growth-stage capital for UK companies, with many scaling firms relocating fundraising to the United States. Closing that gap will require not one LTAF but many, and a willingness among pension trustees to accept the return volatility that venture capital entails.

For now, Schroders' deployment marks a structural milestone: pension capital is reaching UK venture-backed companies through a regulated vehicle for the first time. Whether it becomes a sustained flow or remains a carefully managed trickle will depend on returns, regulation, and the willingness of pension boards to tolerate a fundamentally different risk profile.